Tolerance and Efficacy Nicotinamide (Vitamin B3) in Dominant Optic Atrophy OPA1
Clinical trial NCT06007391 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06007391
- Sponsor
- University Hospital, Angers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-23
- Primary completion
- 2026-09-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.